Weekly briefings on funding, launches, leadership moves and hiring signals across life sciences and industrial markets, written by the QP Group specialists who work in them every day.
Funding, launches, leadership moves and hiring signals across the companies building the future of science and healthcare.
Infrastructure funding, contractor consolidation, project awards and leadership moves across US construction and manufacturing.
The stories that mattered last week, across every market we cover.
They join the push to speed up prior authorization and make it more transparent by 2027. Big Tech is moving into payer workflows.
Read the source →Supplemental SRF funding ended on 30 Sept, and contractors are pushing Congress to reauthorise at IIJA levels. Without that, federal water funding could fall by about 60% in FY27.
Read the source →27 companies cut 2,568 people, about 90% fewer than a year ago and the lowest quarter since BioSpace started tracking. New Jersey was hit hardest.
Read the source →Agents now run whole R&D workflows, with scientists approving key steps. Benchling calls agents its fastest-growing product.
Read the full story →A CMS deputy administrator said “a lot of things” about the AI-assisted Medicare prior auth pilot running in six states are not working. Expect more scrutiny of AI-led denials.
Read the source →Rhode Island won $38.8M of DWSRF funding for lead service line replacement, 35% above its normal allotment, and Providence Water secured $26.2M for about 2,000 more replacements.
Read the source →Tango is cutting 14%, mostly research staff. EyePoint is halving its workforce, Foghorn is cutting 40%, and GSK plans 1,200+ cuts in Belgium.
Read the source →AI turns plain-English SOPs into GxP-ready workflows from research to production, shipping in December.
Read the source →Its ambient AI now links clinical documentation to financial workflows, and it works with 250+ healthcare organisations.
Read the source →A Texas judge refused to shut the ethylene pipeline feeding the plant, which protects 400+ jobs. An appeal is still possible.
Read the source →GSK is putting $800M into biologics production in Pennsylvania, creating 300+ jobs.
Read the source →Drug-programme coordination agents are being folded into OpenAI’s Rosalind life sciences suite. The AI labs are now chasing R&D software budgets.
Read the source →Read any newsletter in full.
26 Oct 2026 · Digital Health & Healthcare AI
26 Oct 2026 · HDPE Pipe
26 Oct 2026 · Talent & Hiring
26 Oct 2026 · Life Science Software
A three-minute weekly read: funding, launches, leadership moves and what they mean for hiring. No spam, one-click unsubscribe.
